These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37242149)

  • 21. Ultra-processed food and risk of type 2 diabetes: a systematic review and meta-analysis of longitudinal studies.
    Delpino FM; Figueiredo LM; Bielemann RM; da Silva BGC; Dos Santos FS; Mintem GC; Flores TR; Arcêncio RA; Nunes BP
    Int J Epidemiol; 2022 Aug; 51(4):1120-1141. PubMed ID: 34904160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impacts of Consumption of Ultra-Processed Foods on the Maternal-Child Health: A Systematic Review.
    de Oliveira PG; de Sousa JM; Assunção DGF; de Araujo EKS; Bezerra DS; Dametto JFDS; Ribeiro KDDS
    Front Nutr; 2022; 9():821657. PubMed ID: 35634416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultra-processed food and incident type 2 diabetes: studying the underlying consumption patterns to unravel the health effects of this heterogeneous food category in the prospective Lifelines cohort.
    Duan MJ; Vinke PC; Navis G; Corpeleijn E; Dekker LH
    BMC Med; 2022 Jan; 20(1):7. PubMed ID: 35022060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the gut microbiota of women according to ultra-processed food consumption.
    Fernandes AE; Rosa PWL; Melo ME; Martins RCR; Santin FGO; Moura AMSH; Coelho GSMA; Sabino EC; Cercato C; Mancini MC
    Nutr Metab Cardiovasc Dis; 2023 Jan; 33(1):84-89. PubMed ID: 36411218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultraprocessed Food Consumption and Risk of Type 2 Diabetes Among Participants of the NutriNet-Santé Prospective Cohort.
    Srour B; Fezeu LK; Kesse-Guyot E; Allès B; Debras C; Druesne-Pecollo N; Chazelas E; Deschasaux M; Hercberg S; Galan P; Monteiro CA; Julia C; Touvier M
    JAMA Intern Med; 2020 Feb; 180(2):283-291. PubMed ID: 31841598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.
    Mantovani A; Petracca G; Beatrice G; Csermely A; Tilg H; Byrne CD; Targher G
    Gut; 2022 Apr; 71(4):778-788. PubMed ID: 33685968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
    Azevedo VZ; Dall'Alba V
    Clin Nutr; 2021 Jun; 40(6):4275-4283. PubMed ID: 33551215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultra-processed food consumption and metabolic syndrome: a cross-sectional study in Quilombola communities of Alagoas, Brazil.
    Barbosa LB; Vasconcelos NBR; Dos Santos EA; Dos Santos TR; Ataide-Silva T; Ferreira HDS
    Int J Equity Health; 2023 Jan; 22(1):14. PubMed ID: 36650595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.
    Mantovani A; Petracca G; Beatrice G; Tilg H; Byrne CD; Targher G
    Gut; 2021 May; 70(5):962-969. PubMed ID: 32938692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between ultra-processed food consumption and gut microbiota in senior subjects with overweight/obesity and metabolic syndrome.
    Atzeni A; Martínez MÁ; Babio N; Konstanti P; Tinahones FJ; Vioque J; Corella D; Fitó M; Vidal J; Moreno-Indias I; Pertusa-Martinez S; Álvarez-Sala A; Castañer O; Goday A; Damas-Fuentes M; Belzer C; Martínez-Gonzalez MÁ; Hu FB; Salas-Salvadó J
    Front Nutr; 2022; 9():976547. PubMed ID: 36299993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.
    Lombardi R; Onali S; Thorburn D; Davidson BR; Gurusamy KS; Tsochatzis E
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011640. PubMed ID: 28358980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultra-processed food intake and risk of depression: a systematic review.
    Tian YR; Deng CY; Xie HC; Long QJ; Yao Y; Deng Y; Zhao H; Li Y; Liu H; Xiao L
    Nutr Hosp; 2023 Feb; 40(1):160-176. PubMed ID: 36537321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials.
    Peng X; Li J; Zhao H; Lai J; Lin J; Tang S
    BMC Endocr Disord; 2022 Apr; 22(1):95. PubMed ID: 35399069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low physical activity and energy dense Malaysian foods are associated with non-alcoholic fatty liver disease in centrally obese but not in non-centrally obese patients with diabetes mellitus.
    Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
    Asia Pac J Clin Nutr; 2015; 24(2):289-98. PubMed ID: 26078246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultra-processed food consumption and obesity indicators in individuals with and without type 1 diabetes mellitus: a longitudinal analysis of the prospective Coronary Artery Calcification in Type 1 Diabetes (CACTI) cohort study.
    Pang T; Gray HL; Alman AC; Buro AW; Basu A; Lu S; Snell-Bergeon JK
    Public Health Nutr; 2023 Aug; 26(8):1626-1633. PubMed ID: 37129091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
    Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
    Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response meta-analysis of ultra-processed food with the risk of cardiovascular events and all-cause mortality: evidence from prospective cohort studies.
    Yuan L; Hu H; Li T; Zhang J; Feng Y; Yang X; Li Y; Wu Y; Li X; Huang H; Hu F; Chen C; Zhang M; Zhao Y; Hu D
    Food Funct; 2023 Mar; 14(6):2586-2596. PubMed ID: 36866803
    [No Abstract]   [Full Text] [Related]  

  • 40. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
    Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
    BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.